In a limited NSCLC EGFR mutated T790M positive population, we confirmed the role of the plasma with a sensitivity/concordance about of 60%, showing, however, disappointing results for urine and EBC. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.